Analysen zu AstraZeneca PLC
| 06.02.25 | AstraZeneca Neutral | UBS AG | |
| 06.02.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 20.01.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.01.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | AstraZeneca Outperform | Bernstein Research | |
| 06.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.12.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 16.12.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 10.12.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.12.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 20.11.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.11.24 | AstraZeneca Neutral | UBS AG | |
| 13.11.24 | AstraZeneca Halten | DZ BANK | |
| 13.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 13.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | AstraZeneca Sell | UBS AG | |
| 12.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 08.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.11.24 | AstraZeneca Sell | UBS AG | |
| 06.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 06.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 05.11.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 05.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 04.11.24 | AstraZeneca Sell | UBS AG | |
| 04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.10.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.10.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.10.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 08.10.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.10.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 25.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 18.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.09.24 | AstraZeneca Sell | UBS AG | |
| 13.09.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 10.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. |
Aktuelle Aktienanalysen
| 06.08.26 | Rheinmetall Neutral | JP Morgan Chase & Co. | |
| 06.08.26 | Kontron Buy | Jefferies & Company Inc. | |
| 06.08.26 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 06.08.26 | Rheinmetall Buy | Goldman Sachs Group Inc. | |
| 06.08.26 | Rheinmetall Buy | Goldman Sachs Group Inc. | |
| 06.08.26 | RATIONAL Outperform | Bernstein Research | |
| 06.08.26 | Commerzbank Outperform | RBC Capital Markets | |
| 06.08.26 | Siemens Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | Scout24 Outperform | Bernstein Research | |
| 06.08.26 | Rheinmetall Buy | UBS AG | |
| 06.08.26 | Siemens Sector Perform | RBC Capital Markets | |
| 06.08.26 | Carl Zeiss Meditec Market-Perform | Bernstein Research | |
| 06.08.26 | Scout24 Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | Zurich Insurance Outperform | RBC Capital Markets | |
| 06.08.26 | Swiss Re Hold | Jefferies & Company Inc. | |
| 06.08.26 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 06.08.26 | RENK Buy | Jefferies & Company Inc. | |
| 06.08.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 06.08.26 | AUMOVIO Hold | Jefferies & Company Inc. | |
| 06.08.26 | Akzo Nobel Hold | Jefferies & Company Inc. | |
| 06.08.26 | Porsche vz. Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.08.26 | BBVA Buy | Goldman Sachs Group Inc. | |
| 06.08.26 | Beiersdorf Neutral | Goldman Sachs Group Inc. | |
| 06.08.26 | Basler Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.08.26 | Ahold Delhaize Neutral | Goldman Sachs Group Inc. | |
| 06.08.26 | Wolters Kluwer Neutral | Goldman Sachs Group Inc. | |
| 06.08.26 | Infineon Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | Wolters Kluwer Outperform | Bernstein Research | |
| 06.08.26 | Infineon Buy | Jefferies & Company Inc. | |
| 06.08.26 | Infineon Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.08.26 | Beiersdorf Neutral | UBS AG | |
| 06.08.26 | Springer Nature Buy | Goldman Sachs Group Inc. | |
| 06.08.26 | HENSOLDT Neutral | JP Morgan Chase & Co. | |
| 06.08.26 | Novo Nordisk Neutral | UBS AG | |
| 06.08.26 | Beiersdorf Neutral | JP Morgan Chase & Co. | |
| 06.08.26 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | DHL Group Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | Fresenius Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | Beiersdorf Underweight | Barclays Capital | |
| 06.08.26 | Vonovia Buy | Jefferies & Company Inc. | |
| 05.08.26 | L'Oréal Hold | Jefferies & Company Inc. | |
| 05.08.26 | Vestas Wind Systems A-S Overweight | JP Morgan Chase & Co. | |
| 05.08.26 | Continental Overweight | JP Morgan Chase & Co. | |
| 05.08.26 | Springer Nature Overweight | JP Morgan Chase & Co. | |
| 05.08.26 | AMD Sector Perform | RBC Capital Markets | |
| 05.08.26 | SpaceX Outperform | RBC Capital Markets | |
| 05.08.26 | SpaceX Overweight | JP Morgan Chase & Co. | |
| 05.08.26 | GEA Outperform | RBC Capital Markets | |
| 05.08.26 | HENSOLDT Hold | Jefferies & Company Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.